4//SEC Filing
Hammill Kevin Austin 4
Accession 0001209191-20-027194
CIK 0001441693other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:09 PM ET
Size
8.2 KB
Accession
0001209191-20-027194
Insider Transaction Report
Form 4
Hammill Kevin Austin
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2020-05-01+35,492→ 35,492 total→ Common Stock (35,492 underlying) - Award
Restricted Stock Units
2020-05-01+89,915→ 89,915 total→ Common Stock (89,915 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- [F2]The restricted stock units fully vested on the grant date. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- [F3]The restricted stock units vest in three equal installments on each of June 30, 2020, September 30, 2020 and December 31, 2020. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
Documents
Issuer
MARRONE BIO INNOVATIONS INC
CIK 0001441693
Entity typeother
Related Parties
1- filerCIK 0001739741
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:09 PM ET
- Size
- 8.2 KB